Transcriptomics

Dataset Information

0

Expression profile of MM.1S tumors folloiwing treatment with bortezomib

ABSTRACT: MM.1S orthotopic tumors were analyzed fro their gene expression upon tumor outgrowth. In contorl/bortezomib/elesclmol and combo treatments.

ORGANISM(S): Homo sapiens

PROVIDER: GSE123637 | GEO | 2019/03/27

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Expression profile of MM.1S tumors folloiwing treatment with bortezomib
| PRJNA509438 | ENA
Proteomics Global proteomics in MM.1S treated with pomalidomide or dipeptides
2022-07-28 | PXD025336 | Pride
Transcriptomics mRNA-sequencing for MM.1S cells that were treated with pomalidomide or were expressing shRNA against ARID2 or Aiolos.
2020-07-22 | GSE126463 | GEO
Genomics An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma
| PRJNA985655 | ENA
Transcriptomics A Subset of Genes Can Distinguish between Bortezomib Responsive Versus Bortezomib Resistant Myeloma
2013-11-01 | GSE51940 | GEO
Genomics Vibrio splendidus 1S-124
| PRJNA167018 | ENA
Transcriptomics Transcription profiling of human U266, MM.1s, KMS11, 8226/S multiple myeloma cell lines treated with arsenic
2009-02-01 | E-GEOD-14519 | biostudies-arrayexpress
Transcriptomics Roles of Iron in Chemoresistance of Multiple Myeloma Depends on the Interaction with Bone Marrow Stromal Cells [treatment]
2022-10-07 | GSE214766 | GEO
Genomics Expression profile of Lo19S state cells and MM.1S tumors
| PRJNA509434 | ENA
Genomics MicroRNA Expression Profile of serum exosomes from Bortezomib-resistant and Bortezomib-response patients in multiple myeloma
2016-07-31 | GSE71435 | GEO